6039
Japan Animal Referral Medical Center Co.,Ltd.
日本動物高度医療センター
- Industry
- Services
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Notes
- Stock adjustmentsDec 17, 2025 Stock split 1 share → 5 shares
Key metrics
Revenue(thousand JPY)
Mar 2022
2,979,011
Mar 2023
3,872,994
Mar 2024
4,270,195
Mar 2025
5,277,736
Mar 2026
6,192,468
Operating profit(thousand JPY)
Mar 2022
439,236
Mar 2023
580,548
Mar 2024
496,919
Mar 2025
720,974
Mar 2026
1,150,238
Operating profit margin(%)
Mar 2022
14.74
Mar 2023
14.99
Mar 2024
11.64
Mar 2025
13.66
Mar 2026
18.57
Profit before tax(thousand JPY)
Mar 2022
423,583
Mar 2023
533,932
Mar 2024
491,305
Mar 2025
720,263
Mar 2026
1,142,017
Profit(thousand JPY)
Mar 2022
286,939
Mar 2023
380,664
Mar 2024
337,217
Mar 2025
520,982
Mar 2026
833,428
Total assets(thousand JPY)
Mar 2022
6,966,910
Mar 2023
8,578,896
Mar 2024
8,770,036
Mar 2025
8,753,719
Mar 2026
11,313,989
Cash and cash equivalents(thousand JPY)
Mar 2022
968,595
Mar 2023
1,816,039
Mar 2024
1,337,639
Mar 2025
1,107,603
Mar 2026
1,592,885
Cash flows from operating activities(thousand JPY)
Mar 2022
557,574
Mar 2023
810,922
Mar 2024
899,782
Mar 2025
1,372,376
Mar 2026
1,395,827
Cash flows from investing activities(thousand JPY)
Mar 2022
-1,425,741
Mar 2023
-784,065
Mar 2024
-985,860
Mar 2025
-994,383
Mar 2026
-2,486,034
Cash flows from financing activities(thousand JPY)
Mar 2022
722,091
Mar 2023
820,586
Mar 2024
-392,322
Mar 2025
-608,029
Mar 2026
1,575,489
Return on equity(%)
Mar 2022
11.8
Mar 2023
12.2
Mar 2024
9
Mar 2025
13.1
Mar 2026
18.5
Equity ratio(%)
Mar 2022
36
Mar 2023
43.2
Mar 2024
43.5
Mar 2025
47.4
Mar 2026
43.1
Earnings per share(JPY per share)
Mar 2022
24.19
Mar 2023
31.266
Mar 2024
24.602
Mar 2025
40.224
Mar 2026
64.48
Net assets per share(JPY per share)
Mar 2022
215.76
Mar 2023
270.998
Mar 2024
289.304
Mar 2025
320.998
Mar 2026
377.68
Dividend per share(JPY per share)
Mar 2022
-
Mar 2023
-
Mar 2024
4
Mar 2025
7.4
Mar 2026
12
Payout ratio(%)
Mar 2022
-
Mar 2023
-
Mar 2024
16.26
Mar 2025
18.4
Mar 2026
18.61
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.